Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma

2015 ◽  
Vol 10 (1) ◽  
pp. 171-178 ◽  
Author(s):  
Hannah A. Blair ◽  
Greg L. Plosker
1995 ◽  
Vol 2 (2) ◽  
pp. 107327489500200
Author(s):  
Christopher L. Alexander ◽  
Roberto E. Izquierdo ◽  
James Figge ◽  
John Horton

Thyroid carcinoma, which comprises the majority of endocrine malignancies, has a substantial annual morbidity and mortality based on age and other predisposing factors. Diagnosis of a growing thyroid nodule can be difficult, but ultrasonography, radionuclide scanning, and fine needle aspiration allow the majority of nodules to be properly characterized. Treatment of differentiated thyroid carcinoma remains controversial. Surgical resection continues to be the most important modality with long survival if the tumor is resected early. Newer imaging techniques have improved the diagnosis of locally recurrent or metastatic disease. Radioactive iodine ablation is indicated for patients with “high-risk” tumors or advanced age. Few patients respond to cytotoxic chemotherapy. In the past decade, advances in the screening and diagnosis of medullary thyroid carcinoma have led to earlier detection with improvement in survival.


Thyroid ◽  
2016 ◽  
Vol 26 (11) ◽  
pp. 1623-1629 ◽  
Author(s):  
Rafael Selbach Scheffel ◽  
André B. Zanella ◽  
José Miguel Dora ◽  
Ana Luiza Maia

Thyroid ◽  
2020 ◽  
Vol 30 (5) ◽  
pp. 732-738 ◽  
Author(s):  
Eyun Song ◽  
Mijin Kim ◽  
Eui Young Kim ◽  
Bo Hyun Kim ◽  
Dong Yeob Shin ◽  
...  

1997 ◽  
Vol 47 (6) ◽  
pp. 713-720 ◽  
Author(s):  
D. M. V. Pelikan ◽  
H. L. Lion ◽  
J. Hermans ◽  
B. M. Goslings

2012 ◽  
Vol 2012 ◽  
pp. 1-3
Author(s):  
Ash Gargya ◽  
Elizabeth Chua

Background. False-positive pulmonary radioactive iodine uptake in the followup of differentiated thyroid carcinoma has been reported in patients with certain respiratory conditions.Patient Findings. We describe a case of well-differentiated papillary thyroid carcinoma treated by total thyroidectomy and radioiodine ablation therapy. Postablation radioiodine whole body scan and subsequent diagnostic radioiodine whole body scans have shown persistent uptake in the left hemithorax despite an undetectable stimulated serum thyroglobulin in the absence of interfering thyroglobulin antibodies. Contrast-enhanced chest computed tomography has confirmed that the abnormal pulmonary radioiodine uptake correlates with focal bronchiectasis.Summary. Bronchiectasis can cause abnormal chest radioactive iodine uptake in the followup of differentiated thyroid carcinoma.Conclusions. Recognition of potential false-positive chest radioactive iodine uptake, simulating pulmonary metastases, is needed to avoid unnecessary exposure to further radiation from repeated therapeutic doses of radioactive iodine.


Sign in / Sign up

Export Citation Format

Share Document